US · YDESW
YD Bio Limited Warrants
- Sector
- Healthcare · Biotechnology
- Headquarters
- Taipei 115001
- Website
- ydesgroup.com
Price at previous close
$0.24
Market cap 1.21M
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | $0.00 | $0.00 | |||
| 2025 | $0.00 | $0.00 |
Line items
Line items
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | Model Valuation | Core Valuation | Growth | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| YDESW | YD Bio Limited Warrants | $0.24 | 1.21M | — | — | — | — | — | — | — | — | — |
| CMND | Clearmind Medicine Inc. | $2.45 | 2.5M | — | — | — | — | -0.08 | 0.25 | — | 0.94 | — |
| KZIA | Kazia Therapeutics Limite… | $12.67 | 20.52M | +37% | -76% | — | +9,097% | -0.63 | -1.56 | 309.03 | -0.68 | -9818.00% |
| LEXX | Lexaria Bioscience Corp. | $0.62 | 12.68M | +4,509% | -32% | — | — | -1.57 | 6.26 | 26.52 | -1.43 | 5205.00% |
| QLGN | Qualigen Therapeutics, In… | $3.21 | 5.43M | +38,771% | — | — | — | -0.18 | 0.42 | — | 0.01 | -10000.00% |
| SNGX | Soligenix, Inc. | $0.97 | 10.02M | — | — | — | — | -0.48 | 0.96 | — | 0.25 | — |
| SXTP | 60 Degrees Pharmaceutical… | $1.49 | 1.2M | — | — | — | — | — | — | — | — | — |
| XBIO | Xenetic Biosciences, Inc. | $3.08 | 5.82M | — | — | — | — | — | — | — | — | — |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $0.24) − 1 = — (DCF, example).